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Musculoskeletal tissues form part of the skeletal and/or muscular system of the body, 
vital in providing support and mobility. Musculoskeletal tissue transplants outnumber all 
other organ and tissue transplants. The bioburden assessment of allograft 
musculoskeletal tissue must be performed as part of the assessment screening of 
living and cadaveric donors to minimise the potential risk of transmission of infectious 
diseases via the allograft to the recipient. 
 
There are no guidelines or standard method for determining the bioburden assessment 
of allograft musculoskeletal tissue and microbiology laboratories may use different 
types of samples, culture media and methods. Determining the suitability of the 
allograft tissue sample and the sensitivity of the bioburden testing methods required 
investigation especially with the advent of nucleic-acid testing (NAT). Subsequently, 
this investigation highlighted the lack of information regarding microbiology laboratories 
and the tissue banking industry in Australia. 
 
A questionnaire was sent to all Australian tissue banks to determine their current status 
and the types of allograft samples being collected for bioburden assessment. Another 
questionnaire was designed for Therapeutic Goods Administration (TGA) licensed 
clinical microbiology laboratories to establish what bioburden assessment methods 
were being used for allograft samples. The information obtained from these 
questionnaires guided the evaluations undertaken in this thesis to compare different 
allograft samples and methods for bioburden assessment. 
 
The current practice of collecting a swab and biopsy sample of allograft 
musculoskeletal tissue appears optimal for bioburden assessment. Retrospective 
reviews of isolates recovered from allograft musculoskeletal tissue and from the 
literature found a wide range of aerobic and anaerobic micro-organisms with fungi 
infrequently isolated. 
 
An evaluation of the Amies gel swab and the ESwab systems was performed to 
determine if bioburden recovery could be improved at the pre-analytical stage. Both 
swab systems were found to be suitable sampling devices for bioburden testing of 
allograft musculoskeletal tissue. 
xiv 
 
The most common bioburden assessment methods, agar and broth culture, were 
compared with a broad-range NAT method. Swab and biopsy samples were inoculated 
with known quantities of challenge organisms and the percentage recovery of the 
challenge organisms was compared. In this study, the NAT method was not more 
sensitive than the culture-based techniques evaluated with broth culture being the most 
sensitive. 
 
Microbiology laboratories must continue to re-evaluate current methods and investigate 
new ones to improve sensitivity. Future directions must be cost-effective as the value of 
maintaining a TGA-licence has become uncertain for some laboratories. Ultimately, 
tissue banks, clinicians and, most importantly, the allograft recipient must have 
confidence in the pre-analytical sampling techniques and the testing methods used to 
determine the bioburden of allograft musculoskeletal tissue prior to transplant. 
 
 
